CJC-1295 with DAC (Drug Affinity Complex) is a 30-amino acid GHRH analog incorporating Lys-maleimidopropionoyl at the C-terminus, enabling covalent binding to serum albumin and extending its plasma half-life to 6–8 days. This sustained GHRH activity produces continuous elevations in basal GH and IGF-1 levels, distinct from the pulsatile pattern induced by shorter GHRH analogs.
Research Applications:
- Sustained GH axis stimulation and tonic GH secretion models
- IGF-1 upregulation and long-term GH/IGF-1 axis studies
- Pulsatile vs. tonic GH secretion comparative research
- Body composition and metabolic research in animal models
Key Properties:
Modification: Albumin-binding DAC technology
Half-life: ~6–8 days
Molecular Weight: ~3,647 Da
CAS: 863288-34-0
Product Specifications:
Purity: ≥98% (HPLC)
Form: Lyophilized Powder
Storage: −20 °C, protected from light
For research use only. Not for human consumption. Not for veterinary use. No medical or therapeutic claims are made. These statements have not been evaluated by the FDA.

Reviews
There are no reviews yet.